Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial

BACKGROUND: Patients with breast cancer can be affected by cardiotoxic reactions through cancer therapies. Cardiac biomarkers, like NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) and high‐sensitivity cardiac troponin T, might have predictive value. METHODS AND RESULTS: Echocardiography, ECG,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Rüger, Alexandra Maria, Schneeweiss, Andreas, Seiler, Sabine, Tesch, Hans, van Mackelenbergh, Marion, Marmé, Frederik, Lübbe, Kristina, Sinn, Bruno, Karn, Thomas, Stickeler, Elmar, Müller, Volkmar, Schem, Christian, Denkert, Carsten, Fasching, Peter A., Nekljudova, Valentina, Garfias‐Macedo, Tania, Hasenfuß, Gerd, Haverkamp, Wilhelm, Loibl, Sibylle, von Haehling, Stephan
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7763783/
https://ncbi.nlm.nih.gov/pubmed/33191846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.018143
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars